Mayo Clinic Proceedings
Avatar

What Is the Effect of Omega-3 on Cardiovascular Outcomes? Should This Be Standard Preventive Treatment?

By Mayo Clinic Proceedings FEATURING Carl Lavie
By Mayo Clinic Proceedings FEATURING Carl Lavie
0 views
September 22, 2020
Comments 5
Login to view comments. Click here to Login

Featured Video

15:01
Lilly Diabetes

Discover the MOA of an Incretin Medication for T2D

Featured Video

18:06
Lilly Obesity

Getting Patients Started with an Obesity Treatment Option for Adults

Feat. E. Lazarus

Recommended

AUTOPLAY
28:13
National Lipid Association

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

Feat. R. Mason
22:22
Practical Ways to Achieve Targets in Diabetes Care

Omega-3 Fatty Acids and Cardiovascular Outcomes: Anatomy of a Fish T…

Feat. S. Nissen
29:14
Michael Ozner

The Role of Omega-3 Fatty Acids for the Treatment and Prevention of …

33:20
Top Ten Topics in Clinical Cardiology 2023

Reinterrogating the Triglyceride Role in CAD Newer Therapies and Sup…

Feat. D. Bhatt
20:26
Canadian Collaborative Research Network

Cardiovascular Risk Reduction: More Than Just LDL-Cholesterol

Feat. D. Bhatt
18:02
San Diego Heart Failure Symposium for Primary Care and Internal Medicine Physicians

Novelties in Lipid Lowering Therapies: Can Statin Therapy Reduce Res…

Feat. P. Taub
16:57
Penn Medicine Heart and Vascular Center

How Do I Address Triglycerides?

Feat. M. Miller
15:16
The Texas Heart Institute

Updates in Guidelines for the Management of Chronic Coronary Artery …

Feat. S. Virani
47:01
Norman Lepor

Remnant Lipoproteins: The Rediscovered CVD Risk Factor - Are We Miss…

28:29
Practical Ways to Achieve Targets in Diabetes Care

The Epidemic of Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Al…

Feat. S. Nissen
45:19
ASPC 2019 Congress on CVD Prevention

REDUCE-IT and Treating Beyond LDL-C Lowering

Feat. D. Bhatt
21:27
13th Orange County Symposium for Cardiovascular Disease Prevention

Novel Lipid-Lowering Drug Development Beyond Statins

Feat. M. Wilkinson
15:21
26th Annual San Diego Heart Failure Symposium

Advances in Treating Hyperlipidemia: What Are the Results of Trials …

Feat. P. Taub
16:27
Cedars Sinai

EPA Fish Oil: Who Should Get It?

Feat. P. Toth
20:34
Canadian Collaborative Research Network

Decoding the Cardiovascular Benefits of Icosapent Ethyl

Feat. D. Bhatt
48:43
University of Colorado Department of Medicine

Beyond LDL: Assessing and Treating Residual ASCVD Risk

Feat. M. Cornier
15:08
Cardiology Pulse 2019

Top 5 Cardiovascular Prevention Trials

Feat. R. Chilton
19:57
National Lipid Association

Results of REDUCE-IT

Feat. M. Miller
21:20
National Lipid Association

Medical Nutrition Therapy for Hypertriglyceridemia: Where do Omega-3…

Feat. T. Severson
22:34
MUSC Cardiology

Targeting Triglyceride-rich Lipoproteins and Their Remnants

Feat. M. Cornier